Tayyaba Rafiq, et al. “THE PROGNOSTIC SIGNIFICANCE OF PD-L1 EXPRESSION IN IMMUNE CHECKPOINT THERAPY FOR DIVERSITY IN HEAD AND NECK TUMORS ASSESSMENTS, INSIGHTS TO MOLECULAR ONCOLOGY THERAPEUTICS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 8, Aug. 2024, pp. 3453-9, https://doi.org/10.53555/gh4hse49.